A detailed history of State Street Corp transactions in Nkarta, Inc. stock. As of the latest transaction made, State Street Corp holds 1,098,062 shares of NKTX stock, worth $2.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,098,062
Previous 1,082,493 1.44%
Holding current value
$2.96 Million
Previous $6.4 Million 22.42%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.52 - $8.0 $70,371 - $124,552
15,569 Added 1.44%
1,098,062 $4.96 Million
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $2.39 Million - $4.91 Million
453,338 Added 72.06%
1,082,493 $6.4 Million
Q1 2024

May 15, 2024

BUY
$5.59 - $15.71 $96,740 - $271,877
17,306 Added 2.83%
629,155 $6.8 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $5,953 - $29,997
4,545 Added 0.75%
611,849 $4.04 Million
Q3 2023

Nov 14, 2023

BUY
$1.39 - $2.29 $12,576 - $20,719
9,048 Added 1.51%
607,304 $844,000
Q2 2023

Aug 14, 2023

BUY
$2.19 - $5.17 $34,698 - $81,913
15,844 Added 2.72%
598,256 $1.31 Million
Q1 2023

May 15, 2023

BUY
$3.37 - $6.3 $31,061 - $58,067
9,217 Added 1.61%
582,412 $2.07 Million
Q4 2022

Feb 14, 2023

SELL
$5.14 - $14.35 $8.86 Million - $24.7 Million
-1,723,281 Reduced 75.04%
573,195 $3.43 Million
Q3 2022

Nov 15, 2022

BUY
$12.27 - $18.39 $11.5 Million - $17.2 Million
936,861 Added 68.91%
2,296,476 $30.2 Million
Q2 2022

Aug 15, 2022

BUY
$7.77 - $19.44 $8.42 Million - $21.1 Million
1,083,297 Added 392.05%
1,359,615 $16.8 Million
Q1 2022

May 16, 2022

BUY
$8.66 - $14.99 $24,299 - $42,061
2,806 Added 1.03%
276,318 $3.14 Million
Q4 2021

Feb 14, 2022

SELL
$12.79 - $26.88 $11.4 Million - $23.9 Million
-888,088 Reduced 76.45%
273,512 $4.2 Million
Q3 2021

Nov 15, 2021

SELL
$26.67 - $38.76 $1.62 Million - $2.36 Million
-60,867 Reduced 4.98%
1,161,600 $32.3 Million
Q2 2021

Aug 16, 2021

BUY
$23.94 - $36.68 $193,363 - $296,264
8,077 Added 0.67%
1,222,467 $38.7 Million
Q1 2021

May 17, 2021

BUY
$31.33 - $59.61 $21.9 Million - $41.7 Million
699,188 Added 135.71%
1,214,390 $40 Million
Q4 2020

Feb 16, 2021

BUY
$27.03 - $75.62 $7.71 Million - $21.6 Million
285,338 Added 124.13%
515,202 $31.7 Million
Q3 2020

Nov 10, 2020

BUY
$23.52 - $47.9 $5.41 Million - $11 Million
229,864 New
229,864 $6.91 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $131M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.